Pediatric Pulmonology · 2002 · 33 citations · 10 references
PharmacyPharmacologyPharmacotherapyClinical PharmacologyPediatric PharmacotherapyPediatric PulmonologyAsthma PharmacotherapyPediatric Clinical TrialsChildhood Asthma ManagementLocal InfectionLocal Side EffectsPediatric Asthma PharmacotherapySevere Asthma ManagementSevere Asthma TreatmentSteroid Dose ResponseSymptomatic Therapy
A continuous subcutaneous infusion of terbutaline (CSIT) was used to treat 8 children with chronic severe asthma who continued to experience frequent symptoms, despite treatment with regular oral prednisolone. Five patients experienced a symptomatic improvement from CSIT, leading to a reduction in regular medication. Three patients did not experience any lasting benefit from CSIT. The most common side effects were related to the infusion site (bruising and local infection). CSIT may lead to an improvement in symptoms and a reduction in oral steroid dose in selected children with chronic severe asthma. These initial findings support the need for further controlled studies to evaluate the use of CSIT in severe childhood asthma.
10
Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease
Bartolomé R. Celli, Gordon L. Snider, John E. Heffner et al. · 1995 · 3.5K citations
Medicine, Surgery, Exercise Testing +16
The British Guidelines on Asthma Management * 1995 Review and Position Statement
Thorax · 1997 · 449 citations